Recent developments with Biolife Solutions Inc (BLFS) have led to the company’s beta value being reach 1.88 cents.

On Tuesday, Biolife Solutions Inc (NASDAQ: BLFS) was -7.89% drop from the session before settling in for the closing price of $25.46. A 52-week range for BLFS has been $8.92 – $26.73.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 57.29%. When this article was written, the company’s average yearly earnings per share was at 67.76%. With a float of $45.08 million, this company’s outstanding shares have now reached $45.17 million.

The extent of productivity of a business whose workforce counts for 414 workers is very important to gauge. In terms of profitability, gross margin is 36.17%, operating margin of -43.64%, and the pretax margin is -47.32%.

Biolife Solutions Inc (BLFS) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Biolife Solutions Inc stocks. The insider ownership of Biolife Solutions Inc is 2.29%, while institutional ownership is 102.76%. The most recent insider transaction that took place on Aug 14 ’24, was worth 171,328. Before that another transaction happened on Jul 01 ’24, when Company’s Chief Human Resources Officer sold 3,000 for $21.03, making the entire transaction worth $63,090. This insider now owns 61,683 shares in total.

Biolife Solutions Inc (BLFS) Latest Financial update

Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.67 earnings per share (EPS) during the time that was less than consensus figure (set at -0.37) by -0.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 67.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.00% during the next five years compared to 0.51% growth over the previous five years of trading.

Biolife Solutions Inc (NASDAQ: BLFS) Trading Performance Indicators

You can see what Biolife Solutions Inc (BLFS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.58.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.45, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.22 in one year’s time.

Technical Analysis of Biolife Solutions Inc (BLFS)

The latest stats from [Biolife Solutions Inc, BLFS] show that its last 5-days average volume of 0.31 million was inferior to 0.38 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 67.97%. Additionally, its Average True Range was 1.32.

During the past 100 days, Biolife Solutions Inc’s (BLFS) raw stochastic average was set at 69.14%, which indicates a significant increase from 22.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.61% in the past 14 days, which was higher than the 54.74% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $23.75, while its 200-day Moving Average is $19.42. Now, the first resistance to watch is $25.27. This is followed by the second major resistance level at $27.09. The third major resistance level sits at $28.08. If the price goes on to break the first support level at $22.46, it is likely to go to the next support level at $21.47. The third support level lies at $19.65 if the price breaches the second support level.

Biolife Solutions Inc (NASDAQ: BLFS) Key Stats

There are 46,069K outstanding shares of the company, which has a market capitalization of 1.08 billion. As of now, sales total 143,270 K while income totals -66,430 K. Its latest quarter income was 28,330 K while its last quarter net income were -20,720 K.